[1]
|
Schlichting, J.A., Soliman, A.S., Schairer, C., Schottenfeld, D. and Merajver, S.D. (2012) Inflammatory and Non- In-flammatory Breast Cancer Survival by Socioeconomic Position in the Surveillance, Epidemiology, and End Results Da-tabase, 1990-2008. Breast Cancer Research and Treatment, 134, 1257-1268.
https://doi.org/10.1007/s10549-012-2133-2
|
[2]
|
van Uden, D.J., Bretveld, R., Siesling, S., de Wilt, J.H. and Blanken-Peeters, C.F. (2017) Inflammatory Breast Cancer in the Netherlands, Improved Survival over the Last Decades. Breast Cancer Research and Treatment, 162, 365-374.
https://doi.org/10.1007/s10549-017-4119-6
|
[3]
|
Hester, R.H., Hortobagyi, G.N. and Lim, B. (2021) Inflammatory Breast Cancer: Early Recognition and Diagnosis Is Critical. American Journal of Obstetrics & Gynecology, 225, 392-396. https://doi.org/10.1016/j.ajog.2021.04.217
|
[4]
|
Ortiz-Soto, G., Babilonia-Díaz, N.S., Lacourt-Ventura, M.Y., Rivera-Rodríguez, D.M., Quiñones-Rodríguez, J.I., Colón-Vargas, M., Almodóvar-Rivera, I., Ferrer-Torres, L.E., Suárez-Arroyo, I.J. and Martínez-Montemayor, M.M. (2023) Metadherin Regulates Inflammatory Breast Cancer Inva-sion and Metastasis. International Journal of Molecular Sciences, 24, Article No. 4694. https://doi.org/10.3390/ijms24054694
|
[5]
|
Faldoni, F.L.C., Rainho, C.A. and Rogatto, S.R. (2020) Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives. Cells, 9, Article No. 1164. https://doi.org/10.3390/cells9051164
|
[6]
|
Vagia, E. and Cristofanilli, M. (2021) New Treatment Strategies for the Inflammatory Breast Cancer. Current Treatment Options in Oncology, 22, Article No. 50. https://doi.org/10.1007/s11864-021-00843-2
|
[7]
|
Robertson, F.M., Bondy, M., Yang, W., Yamauchi, H., Wig-gins, S., Kamrudin, S., Krishnamurthy, S., Le-Petross, H., Bidaut, L., Player, A.N., Barsky, S.H., Woodward, W.A., Buchholz, T., Lucci, A., Ueno, N.T. and Cristofanilli, M. (2010) Inflammatory Breast Cancer: The Disease, the Biology, the Treatment. CA: A Cancer Journal for Clinicians, 60, 351-375. https://doi.org/10.3322/caac.20082
|
[8]
|
Jagsi, R., Mason, G., Overmoyer, B.A., Woodward, W.A., Badve, S., Schneider, R.J., Lang, J.E., Alpaugh, M., et al. (2022) Komen-IBCRF IBC Collaborative in Partnership with the Milburn Foundation. Inflammatory Breast Cancer Defined: Proposed Common Diagnostic Criteria to Guide Treatment and Research. Breast Cancer Research and Treatment, 192, 235-243. https://doi.org/10.1007/s10549-021-06434-x
|
[9]
|
Barkana, B.D., El-Sayed, A., Khaled, R.H., Helal, M., Khaled, H., Deeb, R., et al. (2022) Imaging Modalities in Inflammatory Breast Cancer (IBC) Diagnosis: A Comput-er-Aided Diagnosis System Using Bilateral Mammography Images. Sensors (Basel), 23, Article No. 64. https://doi.org/10.3390/s23010064
|
[10]
|
Rosenbluth, J.M. and Overmoyer, B.A. (2019) Inflammatory Breast Can-cer: A Separate Entity. Current Oncology Reports, 21, Article No. 86. https://doi.org/10.1007/s11912-019-0842-y
|
[11]
|
Chippa, V. and Barazi, H. (2023) Inflammatory Breast Cancer. StatPearls Publishing, Treasure Island.
|
[12]
|
Chainitikun, S., Saleem, S., Lim, B., Valero, V. and Ueno, N.T. (2020) Update on Systemic Treatment for Newly Diagnosed Inflammatory Breast Cancer. Journal of Advanced Research, 29, 1-12.
https://doi.org/10.1016/j.jare.2020.08.014
|
[13]
|
Li, G.X., Tiulim, J.W., Lang, J.E., et al. (2019) Inflammatory Breast Cancer: Diagnostic, Molecular and Therapeutic Considerations. Current Breast Cancer Reports, 11, 335-346. https://doi.org/10.1007/s12609-019-00337-z
|
[14]
|
Di Bonito, M., Cantile, M. and Botti, G. (2019) Pathological and Molecular Characteristics of Inflammatory Breast Cancer. Translational Cancer Research, 8, S449-S456. https://doi.org/10.21037/tcr.2019.03.24
|
[15]
|
Newman, A.B. and Lynce, F. (2023) Tailoring Treatment for Patients with Inflammatory Breast Cancer. Current Treatment Options in Oncology, 24, 580-593. https://doi.org/10.1007/s11864-023-01077-0
|
[16]
|
Ueno, N.T., Espinosa Fernandez, J.R., Cristofanilli, M., Over-moyer, B., Rea, D., Berdichevski, F., El-Shinawi, M., et al. (2018) International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. Journal of Cancer, 9, 1437-1447.
https://doi.org/10.7150/jca.23969
|
[17]
|
Wang, X., Semba, T., Manyam, G.C., Wang, J., Shao, S., Bertucci, F., et al. (2022) EGFR Is a Master Switch between Immunosuppressive and Immunoactive Tumor Microenvironment in Inflam-matory Breast Cancer. Science Advances, 8, eabn7983. https://doi.org/10.1126/sciadv.abn7983
|
[18]
|
Adesoye, T. and Lucci, A. (2021) Current Surgical Management of Inflammatory Breast Cancer. Annals of Surgical Oncology, 28, 5461-5467. https://doi.org/10.1245/s10434-021-10522-z
|
[19]
|
Nakhlis, F. (2022) Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? Annals of Surgical Oncology, 29, 6106-6113. https://doi.org/10.1245/s10434-022-12138-3
|
[20]
|
Kong, J., Bandyopadhyay, S., Chen, W., Al-Mufarrej, F., Choi, L. and Kosir, M.A. (2023) Improved Rate of Negative Margins for Inflammatory Breast Cancer Using Intraoperative Frozen Section Analysis. Cancers (Basel), 15, Article No. 4597. https://doi.org/10.3390/cancers15184597
|
[21]
|
Koh, E.H., Buzdar, A.U., Ames, F.C., Singletary, S.E., McNeese, M.D., Frye, D., et al. (1990) Inflammatory Carcinoma of the Breast: Results of a Combined-Modality Approach—M.D. Anderson Cancer Center Experience. Cancer Chemotherapy and Pharmacology, 27, 94-100. https://doi.org/10.1007/BF00689090
|
[22]
|
Yamauchi, H., Woodward, W.A., Valero, V., Alvarez, R.H., Lucci, A., Buchholz, T.A., Iwamoto, T., Krishnamurthy, S., Yang, W., Reuben, J.M., Hortobágyi, G.N. and Ueno, N.T. (2012) In-flammatory Breast Cancer: What We Know and What We Need to Learn. Oncologist, 17, 891-899. https://doi.org/10.1634/theoncologist.2012-0039
|
[23]
|
Adesoye, T., Sun, S.X., Schaverien, M.V., Woodward, W.A. and Lucci, A. (2022) Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet? Annals of Surgical Oncology, 29, 4019-4021.
https://doi.org/10.1245/s10434-022-11788-7
|
[24]
|
Chen, J.C., Li, Y., Fisher, J.L., et al. (2022) Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of Surgical Oncology, 29, 6681-6688. https://doi.org/10.1245/s10434-022-11975-6
|
[25]
|
隋大星. 预测M0期炎性乳癌术后生存的新N分期系统[D]: [硕士学位论文]. 大连: 大连医科大学, 2022.
|
[26]
|
Van Berckelaer, C., Rypens, C., van Dam, P., Pouillon, L., Parizel, M., Schats, K.A., Kockx, M., et al. (2019) Infiltrating Stromal Immune Cells in Inflammatory Breast Cancer Are Associated with an Improved Outcome and Increased PD-L1 Expression. Breast Cancer Research, 21, Article No. 28. https://doi.org/10.1186/s13058-019-1108-1
|
[27]
|
Viale, G., Marra, A., Curigliano, G. and Criscitiello, C. (2019) Toward Precision Medicine in Inflammatory Breast Cancer. Translational Cancer Research, 8, S469-S478. https://doi.org/10.21037/tcr.2019.05.04
|